Dr. Reddy`s Laboratories Operating Income

As of the most recent data (June 2026), RDY shows a operating income of $35B. That compares with $71B in the prior-year period — down 50.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RDY's operating income is now $35B (was $71B) — a 50.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Dr. Reddy`s Laboratories is outperforming or lagging.

Tracking RDY's operating income over time shows whether Dr. Reddy`s Laboratories is scaling, shrinking, or reshaping that part of the business. The current reading is $35B That compares with $71B in the prior-year period — down 50.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Dr. Reddy`s Laboratories's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $35B) with ownership activity and broader fundamentals.

Dr. Reddy`s Laboratories's operating income is $35B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.